May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Ben Westphalen: The 2nd tumour agnostic, biomarker-driven approval in the EU
May 3, 2024, 11:26

Ben Westphalen: The 2nd tumour agnostic, biomarker-driven approval in the EU

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared a post on X:

Big news for European cancer patients.
Selpercatinib has been approved by EU Medicines Agency
for advanced RET fusion positive solid tumours This marks the 2nd tumour agnostic, biomarker-driven approval in the EU.

Read further.
Source: Ben Westphalen/X